CHANGES OF INFLAMMATORY MARKERS ARE INDEPENDENT OF BLOOD PRESSURE- AND LIPID-LOWERING EFFECTS OF ANGIOTENSIN II RECEPTOR BLOCKER AND STATIN COMBINATION THERAPY Article Villevalde S., Kotovskaya Y., Kobalava Z., Mirilashvili T. Journal of Hypertension. Vol. 26. 2008.
CELL CULTURE AS A TESTING SYSTEM FOR LIPID-LOWERING SUBSTANCES Article Jargin S.V. Virchows Archiv-European Journal of Pathology. Springer-Verlag GmbH. Vol. 452. 2008.